Limitations of Biomarkers in Psychiatric Diagnosis

Diagnostic Challenges

Brain imaging findings, such as those from PET imaging, are based on group differences and are not specific enough to serve as diagnostic markers in individual cases, according to the American Journal of Psychiatry 1
The DSM-5 Substance-Related Disorders Work Group concluded that biomarkers are not yet appropriate as diagnostic tests for psychiatric disorders, due to lack of diagnostic specificity 1
Genetic variants in dopamine-related genes show replicated associations with substance use disorders, but these associations have small effects or are rare in many populations, limiting their diagnostic use 1

The American College of Emergency Physicians recommends that diagnostic evaluation should be directed by history and physical examination rather than routine laboratory testing, as this approach can identify 94% of organic causes 2
History and physical examination predict 83-98% of clinically significant abnormalities in psychiatric patients, highlighting the importance of clinical assessment 3
Routine extensive laboratory panels have extremely low yield (0.8-1.4%) when history and physical examination are normal, and false positive laboratory results are 8 times more common than true positives 2

Testing should be selective and targeted based on specific clinical indicators rather than reflexive, according to the Annals of emergency medicine and Praxis Medical Insights 3, 4
Check serum glucose if hypoglycemia or hyperglycemia is suspected based on history or examination, and order electrolytes when medication use, excessive water intake, or clinical presentation suggests metabolic disturbance 3
Obtain CBC when infection is suspected based on fever or immunocompromised status, and use a lower threshold for testing in elderly patients, those with substance abuse history, patients without prior psychiatric history, and those with abnormal vital signs 3, 5

Monitoring plasma concentrations of antipsychotic medications is useful to adjust dosages for optimal receptor blockade, as plasma drug concentrations correlate well with brain concentrations and receptor occupancy, according to the American Journal of Psychiatry 6

Do not order dopamine levels or extensive routine laboratory panels reflexively without clinical indication, and do not assume that any peripheral biomarker can substitute for thorough clinical assessment in psychiatric diagnosis 1, 3, 4
Do not delay psychiatric evaluation waiting for laboratory results in alert, cooperative patients with normal vital signs and noncontributory history and physical examination, and do not overlook high-risk groups who may benefit from targeted medical workup 3, 5, 4, 7

5–17 % of adults with chronic psychiatric disorders have thyroid dysfunction that directly contributes to or worsens their mental‑health symptoms (observational data) 8.
In psychiatric patients with abnormal thyroid tests, 50 % have mental‑illness manifestations that are directly related to the thyroid abnormality, particularly in affective disorders (cohort analysis) 8.

Thyroid‑stimulating hormone (TSH) testing is endorsed as a selective screening test for psychiatric patients, yet it remains frequently omitted in clinical practice (practice guideline) 8.
Selective TSH testing should be performed based on specific clinical indicators—such as affective disorder, age ≥ 65 years, or treatment‑resistant psychiatric symptoms—rather than as a routine blanket test for all psychiatric admissions (expert consensus) 9.

Patients aged ≥ 65 years who present with psychiatric symptoms should undergo TSH measurement (risk‑stratified recommendation) 8.
Individuals with affective disorders (depression, mania, bipolar disorder) constitute a high‑risk group for thyroid dysfunction and warrant targeted TSH assessment (clinical guideline) 8.

For alert, cooperative patients with normal vital signs, obtain TSH selectively when the above high‑risk criteria are met; if TSH is abnormal, follow with free T4 to differentiate overt from subclinical hypothyroidism (step‑wise protocol) 9.
Repeat an abnormal TSH result in 1–3 weeks to distinguish transient stress‑related changes from true thyroid disease (follow‑up recommendation) 9.

Urine drug screens are commonly mandated in psychiatric facilities but provide low clinical utility for patient management (evidence review) 10.
Comprehensive metabolic panels and other extensive laboratory panels have a low diagnostic yield in this population, with false‑positive results occurring approximately eight times more frequently than true positives (diagnostic accuracy study) 11.